N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl ester manufacturers
|
| | N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl ester Basic information | | Preparation |
| Product Name: | N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl ester | | Synonyms: | Carbamic acid,N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]-, ethyl este;N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl ester;ethyl N-[5-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyrazin-2-yl]carbamate;Carbamic acid ethyl este;N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl este;N-[5-[(4-Methylphenyl)sulfony!]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic. acid ethyl ester;Upadacitinib Impurity 15;Ethyl N - [5- [(4-methylphenyl) sulfonyl] -5H-pyrrolo [2,3-B] pyrazin-2-yl] carbamate | | CAS: | 1869118-24-0 | | MF: | C16H16N4O4S | | MW: | 360.39 | | EINECS: | 943-940-5 | | Product Categories: | | | Mol File: | 1869118-24-0.mol | ![N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl ester Structure](CAS/20200611/GIF/1869118-24-0.gif) |
| | N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl ester Chemical Properties |
| density | 1.43±0.1 g/cm3(Predicted) | | storage temp. | Store at Room Tem. | | pka | 9.45±0.43(Predicted) | | InChI | InChI=1S/C16H16N4O4S/c1-3-24-16(21)19-14-10-17-15-13(18-14)8-9-20(15)25(22,23)12-6-4-11(2)5-7-12/h4-10H,3H2,1-2H3,(H,18,19,21) | | InChIKey | NROPCWMCOWTXAZ-UHFFFAOYSA-N | | SMILES | C(OCC)(=O)NC1=CN=C2N(S(C3=CC=C(C)C=C3)(=O)=O)C=CC2=N1 |
| | N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl ester Usage And Synthesis |
| Preparation | N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl ester is prepared from 5-bromo-4,7-diazaindole through a series of substitution reactions with ammonia, p-toluenesulfonyl chloride, and ethyl chloroformate. | | Uses | Used as Upadacitinib intermediate. |
| | N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl ester Preparation Products And Raw materials |
|